{"nctId":"NCT00185458","briefTitle":"Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).","startDateStruct":{"date":"2000-05"},"conditions":["Menopause"],"count":394,"armGroups":[{"label":"LNG IUS","type":"EXPERIMENTAL","interventionNames":["Drug: LNG IUS"]}],"interventions":[{"name":"LNG IUS","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Women with intact uterus, regular menstrual cycles and no previous or current climacteric symptoms.\n\nExclusion Criteria:\n\n* Pregnancy or lactation.\n* Previous pelvic infections.\n* Abnormal bleeding.\n* Abnormal uterine cavity.\n* Uterine polyps.\n* Genital cancer.\n* Liver diseases.\n* Alcoholism or drug abuse.","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"46 Years","maximumAge":"51 Years","stdAges":["ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Bleeding Days","description":"Measured by using Subject Diaries (Subject Reported Data)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Spotting Days","description":"Measured by using Subject Diaries (Subject Reported Data)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"4","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Percentage of Participants With Successful Treatment","description":"Definition of successful treatment:\n\n* Completion of HRT phase, and\n* Both, the number of bleeding days and the number of spotting days during HRT was equal to or less than during contraceptive phase, and\n* The number of bleeding days and the number of spotting days could be calculated for at least 3 out of the first 4 reference periods in HRT","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31","spread":null}]}]}]},{"type":"SECONDARY","title":"Assessment of QOL as Measured by Women's Health Questionnaire","description":"Women's Health Questionnaire (Total Score). For the Total score, the minimum is 36 and maximum is 144. A higher score means the distress and dysfunction are less pronounced.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"104.1","spread":"17.75"},{"groupId":"OG001","value":"114.4","spread":"16.64"},{"groupId":"OG002","value":"112.9","spread":"16.32"}]}]}]},{"type":"SECONDARY","title":"Continuation Rates","description":"Percentage of subjects continuing in the study at the given time points.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Progestogenic Symptom 1: Headache (as Measured by a Visual Analogue Scale (VAS))","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23.9","spread":"23.98"},{"groupId":"OG001","value":"19.1","spread":"22.57"},{"groupId":"OG002","value":"18.2","spread":"23.00"}]}]}]},{"type":"SECONDARY","title":"Progestogenic Symptom 2: Depressive Mood (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.3","spread":"25.69"},{"groupId":"OG001","value":"11.8","spread":"17.31"},{"groupId":"OG002","value":"14.6","spread":"22.10"}]}]}]},{"type":"SECONDARY","title":"Progestogenic Symptom 3: Acne or Greasy Skin (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.9","spread":"14.02"},{"groupId":"OG001","value":"7.3","spread":"15.38"},{"groupId":"OG002","value":"7.6","spread":"15.41"}]}]}]},{"type":"SECONDARY","title":"Progestogenic Symptom 4: Nausea (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.5","spread":"13.57"},{"groupId":"OG001","value":"5.3","spread":"11.96"},{"groupId":"OG002","value":"6.7","spread":"15.32"}]}]}]},{"type":"SECONDARY","title":"Progestogenic Symptom 5: Edema (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.7","spread":"20.30"},{"groupId":"OG001","value":"12.3","spread":"18.93"},{"groupId":"OG002","value":"11.7","spread":"17.65"}]}]}]},{"type":"SECONDARY","title":"Progestogenic Symptom 6: Decreased Libido (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.9","spread":"26.29"},{"groupId":"OG001","value":"15.6","spread":"22.06"},{"groupId":"OG002","value":"17.5","spread":"21.13"}]}]}]},{"type":"SECONDARY","title":"Climacteric Symptom 1: Hot Flushes (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"39.9","spread":"30.21"},{"groupId":"OG001","value":"9.4","spread":"14.88"},{"groupId":"OG002","value":"11.3","spread":"18.65"}]}]}]},{"type":"SECONDARY","title":"Climacteric Symptom 2: Sweating Episodes (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"43.0","spread":"29.40"},{"groupId":"OG001","value":"14.0","spread":"19.95"},{"groupId":"OG002","value":"17.0","spread":"21.97"}]}]}]},{"type":"SECONDARY","title":"Climacteric Symptom 3: Vaginal Dryness (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.8","spread":"27.96"},{"groupId":"OG001","value":"13.1","spread":"20.93"},{"groupId":"OG002","value":"16.7","spread":"23.00"}]}]}]},{"type":"SECONDARY","title":"Climacteric Symptom 4: Sleep Problems (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"39.4","spread":"29.71"},{"groupId":"OG001","value":"17.1","spread":"21.34"},{"groupId":"OG002","value":"19.9","spread":"23.93"}]}]}]},{"type":"SECONDARY","title":"Climacteric Symptom 5: Irritability (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33.1","spread":"27.40"},{"groupId":"OG001","value":"17.2","spread":"19.47"},{"groupId":"OG002","value":"19.4","spread":"20.26"}]}]}]},{"type":"SECONDARY","title":"Climacteric Symptom 6: Breast Tension (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.5","spread":"22.16"},{"groupId":"OG001","value":"13.5","spread":"20.39"},{"groupId":"OG002","value":"13.0","spread":"19.42"}]}]}]},{"type":"SECONDARY","title":"Progestogenic Symptom 7: Hair Loss (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.0","spread":"15.14"},{"groupId":"OG001","value":"9.3","spread":"16.69"},{"groupId":"OG002","value":"9.0","spread":"13.63"}]}]}]},{"type":"SECONDARY","title":"Progestogenic Symptom 8: Greasy Hair (as Measured by a VAS)","description":"Higher value means the symptom is more pronounced. Minimum is 0, maximum is 100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.0","spread":"20.60"},{"groupId":"OG001","value":"11.5","spread":"18.85"},{"groupId":"OG002","value":"11.1","spread":"18.93"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":25,"n":394},"commonTop":["Procedural pain","Headache","Back pain","Influenza","Menopausal symptoms"]}}}